The risk or severity of adverse effects can be increased when bupivacaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when epirizole is combined with acemetacin.


The risk or severity of adverse effects can be increased when pancuronium is combined with buprenorphine.


The risk or severity of adverse effects can be increased when clomipramine is combined with periciazine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with terazosin.


The risk or severity of adverse effects can be increased when nortriptyline is combined with doxepin.


The risk or severity of adverse effects can be increased when amoxapine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when amoxapine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Tramadol is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when methylergonovine is combined with ifosfamide.


The risk or severity of adverse effects can be increased when tetracaine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when docetaxel is combined with moxifloxacin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with sertraline.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when doxepin is combined with ritodrine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with perphenazine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Iloperidone.


The risk or severity of adverse effects can be increased when glyburide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with haloperidol.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with thioridazine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with felbamate.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with indapamide.


The risk or severity of adverse effects can be increased when Vilazodone is combined with desipramine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Halobetasol.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with clomipramine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with alclometasone.


The risk or severity of adverse effects can be increased when butorphanol is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when butorphanol is combined with Halazepam.


The risk or severity of adverse effects can be increased when butorphanol is combined with proparacaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with indapamide.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with levodopa.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with celiprolol.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when methylergonovine is combined with felodipine.


The risk or severity of adverse effects can be increased when morniflumate is combined with aspirin.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Asenapine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when chloroquine is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with maprotiline.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with topiramate.


The risk or severity of adverse effects can be increased when fludiazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Olmesartan.


The risk or severity of adverse effects can be increased when losartan is combined with diflunisal.


The risk or severity of adverse effects can be increased when trandolapril is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with felodipine.


The risk or severity of adverse effects can be increased when levorphanol is combined with fludiazepam.


The risk or severity of adverse effects can be increased when ketoprofen is combined with halcinonide.


The risk or severity of adverse effects can be increased when nimesulide is combined with fenbufen.


The risk or severity of adverse effects can be increased when ketoprofen is combined with difluprednate.


The risk or severity of adverse effects can be increased when nimesulide is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when quetiapine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when loratadine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when carprofen is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Nabilone is combined with paroxetine.


The risk or severity of adverse effects can be increased when levorphanol is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when imipramine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when ondansetron is combined with scopolamine.


The risk or severity of adverse effects can be increased when oxybutynin is combined with orphenadrine.


The risk or severity of adverse effects can be increased when clopidogrel is combined with Olsalazine.


The risk or severity of adverse effects can be increased when diclofenac is combined with Naftifine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Milnacipran is combined with digoxin.


The risk or severity of adverse effects can be increased when Milnacipran is combined with sulpiride.


The risk or severity of adverse effects can be increased when sevoflurane is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when apomorphine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when bepridil is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with Benidipine.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when trimipramine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when meperidine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when sotalol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when doxazosin is combined with hydralazine.


The risk or severity of adverse effects can be increased when floctafenine is combined with mesalamine.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when floctafenine is combined with alclometasone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when Arotinolol is combined with nicardipine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when procyclidine is combined with codeine.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with malathion.


The risk or severity of adverse effects can be increased when loxapine is combined with pimozide.


The risk or severity of adverse effects can be increased when Azelnidipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when codeine is combined with Retigabine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with thiopental.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with triazolam.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with HEROIN.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when olanzapine is combined with phenytoin.


The risk or severity of adverse effects can be increased when ketorolac is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when tolterodine is combined with buprenorphine.


The risk or severity of adverse effects can be increased when secobarbital is combined with levodopa.


The risk or severity of adverse effects can be increased when secobarbital is combined with sevoflurane.


The risk or severity of adverse effects can be increased when proparacaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Metixene is combined with hydromorphone.


The risk or severity of adverse effects can be increased when lisinopril is combined with Olopatadine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when secobarbital is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when secobarbital is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when ipratropium is combined with ATROPINE.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when floctafenine is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Halazepam.


The risk or severity of adverse effects can be increased when methocarbamol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with fluocinonide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with sulpiride.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when salicylamide is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when chloroquine is combined with betamethasone.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when ondansetron is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when oxazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when dyclonine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when oxycodone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Perospirone.


The risk or severity of adverse effects can be increased when dyclonine is combined with triprolidine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with flumethasone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when betaxolol is combined with Torasemide.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with rasagiline.


The risk or severity of adverse effects can be increased when losartan is combined with lisinopril.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Icatibant.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Milnacipran.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with methocarbamol.


The risk or severity of adverse effects can be increased when bupivacaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with triprolidine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Olmesartan is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when maprotiline is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when nimesulide is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when quinidine is combined with HEROIN.


The risk or severity of adverse effects can be increased when valsartan is combined with hydralazine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with methoxamine.


The risk or severity of adverse effects can be increased when nimesulide is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with oxprenolol.


The risk or severity of adverse effects can be increased when tretinoin is combined with leflunomide.


The risk or severity of adverse effects can be increased when gabapentin is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with prazepam.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with quetiapine.


The risk or severity of adverse effects can be increased when butorphanol is combined with D-mannitol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when PSEUDOEPHEDRINE is combined with procarbazine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when butorphanol is combined with mepivacaine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when ketoprofen is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Eplerenone is combined with AMMONIUM CHLORIDE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with baclofen.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with amcinonide.


The risk or severity of adverse effects can be increased when loxapine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with Eplerenone.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with methazolamide.


The risk or severity of adverse effects can be increased when Micafungin is combined with cinnarizine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with desoximetasone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with irbesartan.


The risk or severity of adverse effects can be increased when nicergoline is combined with josamycin.


The risk or severity of adverse effects can be increased when Fludarabine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Nepafenac is combined with aspirin.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with donepezil.


The risk or severity of adverse effects can be increased when Azelnidipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with clemastine.


The risk or severity of adverse effects can be increased when diclofenac is combined with Icatibant.


The risk or severity of adverse effects can be increased when codeine is combined with topiramate.


The risk or severity of adverse effects can be increased when clomipramine is combined with minoxidil.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Apremilast.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with acebutolol.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with enflurane.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with captopril.


The risk or severity of adverse effects can be increased when chloroxine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with bumetanide.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when spironolactone is combined with furosemide.


The risk or severity of adverse effects can be increased when nitric oxide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with triprolidine.


The risk or severity of adverse effects can be increased when resveratrol is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when salicylamide is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when sulconazole is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when sulconazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when pentamidine is combined with nicardipine.


The risk or severity of adverse effects can be increased when pimozide is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with tizanidine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with furosemide.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when butabarbital is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when butabarbital is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when sulpiride is combined with baclofen.


The risk or severity of adverse effects can be increased when propranolol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Caspofungin is combined with nisoldipine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when cetirizine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when difluprednate is combined with enoxacin.


The risk or severity of adverse effects can be increased when butabarbital is combined with Remoxipride.


The risk or severity of adverse effects can be increased when butabarbital is combined with loxapine.


The risk or severity of adverse effects can be increased when clorazepate is combined with oxazepam.


The risk or severity of adverse effects can be increased when amiodarone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Articaine.


The risk or severity of adverse effects can be increased when amoxapine is combined with Almotriptan.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with amoxapine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when hexetidine is combined with Pregabalin.


The risk or severity of adverse effects can be increased when Limaprost is combined with cilostazol.


The risk or severity of adverse effects can be increased when Carbetocin is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when spironolactone is combined with Telmisartan.


The risk or severity of adverse effects can be increased when prazosin is combined with Eplerenone.


The risk or severity of adverse effects can be increased when reserpine is combined with ketamine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when prazosin is combined with methazolamide.


The risk or severity of adverse effects can be increased when isoflurane is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when ketamine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when isoflurane is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Isavuconazole is combined with fluvastatin.


The risk or severity of adverse effects can be increased when Apixaban is combined with meperidine.


The risk or severity of adverse effects can be increased when propofol is combined with dyclonine.


The risk or severity of adverse effects can be increased when scopolamine is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when midazolam is combined with baclofen.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Isavuconazole is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when midazolam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when oxycodone is combined with metolazone.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when pentobarbital is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when ketorolac is combined with Olsalazine.


The risk or severity of adverse effects can be increased when codeine is combined with oxycodone.


The risk or severity of adverse effects can be increased when codeine is combined with buspirone.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when quinapril is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with topiramate.


The risk or severity of adverse effects can be increased when triazolam is combined with carisoprodol.


The risk or severity of adverse effects can be increased when oxycodone is combined with dibucaine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when triazolam is combined with sulpiride.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Flibanserin.


The risk or severity of adverse effects can be increased when propranolol is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with minoxidil.


The risk or severity of adverse effects can be increased when Metipranolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when gabapentin is combined with proparacaine.


The risk or severity of adverse effects can be increased when pentazocine is combined with pimozide.


The risk or severity of adverse effects can be increased when etodolac is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with topiramate.


The risk or severity of adverse effects can be increased when lithium ion is combined with zonisamide.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with sulpiride.


The risk or severity of adverse effects can be increased when indomethacin is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when reserpine is combined with nitrazepam.


The risk or severity of adverse effects can be increased when lithium ion is combined with tiagabine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Retigabine is combined with sertraline.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when benazepril is combined with Nepafenac.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with decamethonium.


The risk or severity of adverse effects can be increased when bromazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when amiodarone is combined with papaverine.


The risk or severity of adverse effects can be increased when buspirone is combined with isoflurane.


The risk or severity of adverse effects can be increased when buspirone is combined with ethotoin.


The risk or severity of adverse effects can be increased when metaraminol is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when zopiclone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when nicergoline is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when zopiclone is combined with benzocaine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with cilnidipine.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when nicergoline is combined with Voriconazole.


The risk or severity of adverse effects can be increased when methysergide is combined with Phenelzine.


The risk or severity of adverse effects can be increased when celecoxib is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when efavirenz is combined with tiagabine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with estazolam.


The risk or severity of adverse effects can be increased when Dothiepin is combined with Vilanterol.


The risk or severity of adverse effects can be increased when estazolam is combined with dibucaine.


The risk or severity of adverse effects can be increased when diazepam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when zaleplon is combined with Normethadone.


The risk or severity of adverse effects can be increased when oxycodone is combined with perphenazine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Torasemide.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with procaine.


The risk or severity of adverse effects can be increased when methysergide is combined with clomiphene.


The risk or severity of adverse effects can be increased when alprazolam is combined with zopiclone.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Melatonin.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with trimipramine.


The risk or severity of adverse effects can be increased when alprazolam is combined with oxymorphone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with ramipril.


The risk or severity of adverse effects can be increased when diazepam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with tiapride.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with nisoldipine.


The risk or severity of adverse effects can be increased when methadone is combined with Halazepam.


The risk or severity of adverse effects can be increased when methadone is combined with proparacaine.


The risk or severity of adverse effects can be increased when barnidipine is combined with selegiline.


The risk or severity of adverse effects can be increased when methadone is combined with indapamide.


The risk or severity of adverse effects can be increased when quetiapine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with estazolam.


The risk or severity of adverse effects can be increased when mesalamine is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Tolcapone is combined with tretinoin.


The risk or severity of adverse effects can be increased when selegiline is combined with apraclonidine.


The risk or severity of adverse effects can be increased when edrophonium is combined with nicotine.


The risk or severity of adverse effects can be increased when edrophonium is combined with Cevimeline.


The risk or severity of adverse effects can be increased when mesalamine is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with amisulpride.


The risk or severity of adverse effects can be increased when alprazolam is combined with Asenapine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when diazepam is combined with baclofen.


The risk or severity of adverse effects can be increased when ondansetron is combined with Melatonin.


The risk or severity of adverse effects can be increased when Tianeptine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with irbesartan.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when diazepam is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Torasemide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when Rufinamide is combined with butalbital.


The risk or severity of adverse effects can be increased when Flibanserin is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Carbetocin is combined with nitrendipine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with flumethasone.


The risk or severity of adverse effects can be increased when thalidomide is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when methysergide is combined with ceritinib.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with scopolamine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Remoxipride.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with levodopa.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with cilazapril.


The risk or severity of adverse effects can be increased when indapamide is combined with papaverine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when estrone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when nabumetone is combined with triamcinolone.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with scopolamine.


The risk or severity of adverse effects can be increased when gabapentin is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with clofazimine.


The risk or severity of adverse effects can be increased when indapamide is combined with nifedipine.


The risk or severity of adverse effects can be increased when clonazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when clozapine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Naftifine is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when clozapine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when nabumetone is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when clozapine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with selegiline.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when indapamide is combined with diazoxide.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with barnidipine.


The risk or severity of adverse effects can be increased when timolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when isradipine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Toloxatone is combined with domperidone.


The risk or severity of adverse effects can be increased when ipratropium is combined with Metixene.


The risk or severity of adverse effects can be increased when acebutolol is combined with penbutolol.


The risk or severity of adverse effects can be increased when Agomelatine is combined with brotizolam.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Olmesartan is combined with alclofenac.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Articaine.


The risk or severity of adverse effects can be increased when carboplatin is combined with leflunomide.


The risk or severity of adverse effects can be increased when antipyrine is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Clevidipine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with quetiapine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with PAMABROM.


The risk or severity of adverse effects can be increased when nilvadipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when haloperidol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when gabapentin is combined with sulpiride.


The risk or severity of adverse effects can be increased when thiopental is combined with fludiazepam.


The risk or severity of adverse effects can be increased when gabapentin is combined with carisoprodol.


The risk or severity of adverse effects can be increased when thiopental is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Torasemide is combined with Olmesartan.


The risk or severity of adverse effects can be increased when Torasemide is combined with isradipine.


The risk or severity of adverse effects can be increased when meperidine is combined with halothane.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Trabectedin.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Retigabine.


The risk or severity of adverse effects can be increased when meperidine is combined with desipramine.


The risk or severity of adverse effects can be increased when triamterene is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when clorazepate is combined with imipramine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with irbesartan.


The risk or severity of adverse effects can be increased when Rufinamide is combined with thiothixene.


The risk or severity of adverse effects can be increased when thiothixene is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when Etidocaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when sulpiride is combined with thiamylal.


The risk or severity of adverse effects can be increased when nicergoline is combined with Conivaptan.


The risk or severity of adverse effects can be increased when thiothixene is combined with flunarizine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with maprotiline.


The risk or severity of adverse effects can be increased when meclizine is combined with sertraline.


The risk or severity of adverse effects can be increased when amobarbital is combined with bromazepam.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when cabergoline is combined with rabeprazole.


The risk or severity of adverse effects can be increased when isoflurane is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when metoclopramide is combined with thioridazine.


The risk or severity of adverse effects can be increased when Articaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with antipyrine.


The risk or severity of adverse effects can be increased when betaxolol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when promethazine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Vildagliptin is combined with quinapril.


The risk or severity of adverse effects can be increased when methysergide is combined with Regorafenib.


The risk or severity of adverse effects can be increased when secobarbital is combined with carisoprodol.


The risk or severity of adverse effects can be increased when tolmetin is combined with carprofen.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with labetalol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with thiopental.


The risk or severity of adverse effects can be increased when amphotericin b is combined with cilazapril.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with doxazosin.


The risk or severity of adverse effects can be increased when lorazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when lorazepam is combined with promazine.


The risk or severity of adverse effects can be increased when procarbazine is combined with Arformoterol.


The risk or severity of adverse effects can be increased when isoflurane is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when lisinopril is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with carvedilol.


The risk or severity of adverse effects can be increased when cabergoline is combined with loratadine.


The risk or severity of adverse effects can be increased when cabergoline is combined with droperidol.


The risk or severity of adverse effects can be increased when epirizole is combined with diflorasone.


The risk or severity of adverse effects can be increased when Articaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Paliperidone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when buspirone is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when ibudilast is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with lisinopril.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when physostigmine is combined with methacholine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when amobarbital is combined with Desloratadine.


The risk or severity of adverse effects can be increased when diflunisal is combined with fluocinonide.


The risk or severity of adverse effects can be increased when imipramine is combined with meclizine.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when selegiline is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when diflunisal is combined with leflunomide.


The risk or severity of adverse effects can be increased when LISURIDE is combined with prednisone.


The risk or severity of adverse effects can be increased when Naftifine is combined with Clobetasone.


The risk or severity of adverse effects can be increased when LISURIDE is combined with astemizole.


The risk or severity of adverse effects can be increased when cabergoline is combined with rivastigmine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with levodopa.


The risk or severity of adverse effects can be increased when resveratrol is combined with difluprednate.


The risk or severity of adverse effects can be increased when hydroxychloroquine is combined with mefloquine.


The risk or severity of adverse effects can be increased when Triflusal is combined with mesalamine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Butethal.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Pregabalin.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with lithium ion.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when bumetanide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Naftifine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Clevidipine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Sodium oxybate is combined with citalopram.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when scopolamine is combined with biperiden.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with ramipril.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with tetracaine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with Amrinone.


The risk or severity of adverse effects can be increased when nitrazepam is combined with levodopa.


The risk or severity of adverse effects can be increased when nitrazepam is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when tizanidine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when triflupromazine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with valsartan.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with floxuridine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Olsalazine is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with levodopa.


The risk or severity of adverse effects can be increased when Clofarabine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when METAXALONE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when olanzapine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when tetracaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Riociguat.


The risk or severity of adverse effects can be increased when zopiclone is combined with amoxapine.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with diflunisal.


The risk or severity of adverse effects can be increased when quazepam is combined with cocaine.


The risk or severity of adverse effects can be increased when quazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with prazosin.


The risk or severity of adverse effects can be increased when procyclidine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when sulindac is combined with acemetacin.


The risk or severity of adverse effects can be increased when Halobetasol is combined with rivastigmine.


The risk or severity of adverse effects can be increased when Halobetasol is combined with physostigmine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with clemastine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with promethazine.


The risk or severity of adverse effects can be increased when Asenapine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Bretylium is combined with Aliskiren.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with venlafaxine.


The risk or severity of adverse effects can be increased when isradipine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when tolmetin is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Arotinolol is combined with minoxidil.


The risk or severity of adverse effects can be increased when Naftifine is combined with desoximetasone.


The risk or severity of adverse effects can be increased when isoflurane is combined with Retigabine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Vinflunine.


The risk or severity of adverse effects can be increased when tolmetin is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when tolmetin is combined with Droxicam.


The risk or severity of adverse effects can be increased when tolmetin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with desipramine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when Propacetamol is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when butorphanol is combined with sulpiride.


The risk or severity of adverse effects can be increased when levodopa is combined with selegiline.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Normethadone.


The risk or severity of adverse effects can be increased when butorphanol is combined with carisoprodol.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Caspofungin.


The risk or severity of adverse effects can be increased when scopolamine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when betamethasone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when loteprednol is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when dipyridamole is combined with cilazapril.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when alprazolam is combined with loxapine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when fosinopril is combined with Naftifine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when nicardipine is combined with quinapril.


The risk or severity of adverse effects can be increased when nicardipine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Carbetocin is combined with doxazosin.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Propacetamol.


The risk or severity of adverse effects can be increased when apomorphine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with labetalol.


The risk or severity of adverse effects can be increased when Cobicistat is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when terazosin is combined with quetiapine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with pimozide.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Gallium nitrate is combined with leflunomide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with ethotoin.


The risk or severity of adverse effects can be increased when Nabilone is combined with metoprolol.


The risk or severity of adverse effects can be increased when clenbuterol is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when nortriptyline is combined with fexofenadine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when nortriptyline is combined with naratriptan.


The risk or severity of adverse effects can be increased when nortriptyline is combined with rizatriptan.


The risk or severity of adverse effects can be increased when Tapentadol is combined with acetazolamide.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with sertraline.


The risk or severity of adverse effects can be increased when clarithromycin is combined with toremifene.


The risk or severity of adverse effects can be increased when topiramate is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when Pipamperone is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when bifonazole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when olanzapine is combined with oxycodone.


The risk or severity of adverse effects can be increased when felodipine is combined with Bretylium.


The risk or severity of adverse effects can be increased when Nebivolol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with estrone.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with buprenorphine.


The risk or severity of adverse effects can be increased when ethotoin is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when ethotoin is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Lurasidone is combined with tetracaine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Pipamperone.


The risk or severity of adverse effects can be increased when clidinium is combined with clomipramine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with dobutamine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when cocaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Micafungin is combined with Pregabalin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Etidocaine.


The risk or severity of adverse effects can be increased when nabumetone is combined with resveratrol.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with dantrolene.


The risk or severity of adverse effects can be increased when mecamylamine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Pizotifen.


The risk or severity of adverse effects can be increased when sulindac is combined with flumethasone.


The risk or severity of adverse effects can be increased when loxapine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when meperidine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with theobromine.


The risk or severity of adverse effects can be increased when quetiapine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when reserpine is combined with diltiazem.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when barnidipine is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with potassium ion.


The risk or severity of adverse effects can be increased when oxaprozin is combined with budesonide.


The risk or severity of adverse effects can be increased when tiagabine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when meclizine is combined with clomipramine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Efonidipine.


The risk or severity of adverse effects can be increased when promazine is combined with topiramate.


The risk or severity of adverse effects can be increased when pramipexole is combined with terazosin.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with medrysone.


The risk or severity of adverse effects can be increased when minoxidil is combined with fosinopril.


The risk or severity of adverse effects can be increased when papaverine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with propranolol.


The risk or severity of adverse effects can be increased when tretinoin is combined with Riociguat.


The risk or severity of adverse effects can be increased when nalbuphine is combined with butamben.


The risk or severity of adverse effects can be increased when amphotericin b is combined with clonidine.


The risk or severity of adverse effects can be increased when nimodipine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when metoprolol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when gabapentin is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with periciazine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with bromazepam.


The risk or severity of adverse effects can be increased when tacrolimus is combined with leflunomide.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with anastrozole.


The risk or severity of adverse effects can be increased when leflunomide is combined with formestane.


The risk or severity of adverse effects can be increased when procarbazine is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when leflunomide is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when protriptyline is combined with Salmeterol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with polythiazide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when diflunisal is combined with methazolamide.


The risk or severity of adverse effects can be increased when loratadine is combined with maprotiline.


The risk or severity of adverse effects can be increased when triflupromazine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Pipotiazine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when nicergoline is combined with clotiazepam.


The risk or severity of adverse effects can be increased when haloperidol is combined with clonazepam.


The risk or severity of adverse effects can be increased when haloperidol is combined with Melatonin.


The risk or severity of adverse effects can be increased when thalidomide is combined with fosinopril.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when reserpine is combined with butamben.


The risk or severity of adverse effects can be increased when lisinopril is combined with celecoxib.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with HEROIN.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when flurazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with bupivacaine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with betamethasone.


The risk or severity of adverse effects can be increased when dicyclomine is combined with butorphanol.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Etomidate.


The risk or severity of adverse effects can be increased when amoxapine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when amoxapine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when procarbazine is combined with bezafibrate.


The risk or severity of adverse effects can be increased when methadone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when hydroxyamphetamine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when Articaine is combined with meclizine.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Spirapril is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with brotizolam.


The risk or severity of adverse effects can be increased when halothane is combined with cilazapril.


The risk or severity of adverse effects can be increased when medrysone is combined with donepezil.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Articaine.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with codeine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Indacaterol.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with penbutolol.


The risk or severity of adverse effects can be increased when labetalol is combined with Riociguat.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Nebivolol.


The risk or severity of adverse effects can be increased when butorphanol is combined with amisulpride.


The risk or severity of adverse effects can be increased when moclobemide is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with scopolamine.


The risk or severity of adverse effects can be increased when carprofen is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when METAXALONE is combined with nefazodone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with zotepine.


The risk or severity of adverse effects can be increased when ethotoin is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when naratriptan is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when terconazole is combined with isradipine.


The risk or severity of adverse effects can be increased when Spirapril is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when chloroquine is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with salicylamide.


The risk or severity of adverse effects can be increased when LISURIDE is combined with pravastatin.


The risk or severity of adverse effects can be increased when methysergide is combined with Enasidenib.


The risk or severity of adverse effects can be increased when trimipramine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when quinidine is combined with Mirabegron.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Agomelatine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with halcinonide.


The risk or severity of adverse effects can be increased when risperidone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Normethadone.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Perospirone.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with alclofenac.


The risk or severity of adverse effects can be increased when risperidone is combined with triazolam.


The risk or severity of adverse effects can be increased when triprolidine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Linagliptin.


The risk or severity of adverse effects can be increased when pramipexole is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when pramipexole is combined with tolazoline.


The risk or severity of adverse effects can be increased when naratriptan is combined with rizatriptan.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with desoximetasone.


The risk or severity of adverse effects can be increased when ipratropium is combined with levorphanol.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Apremilast.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with diflorasone.


The risk or severity of adverse effects can be increased when lisinopril is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with lovastatin.


The risk or severity of adverse effects can be increased when triazolam is combined with maprotiline.


The risk or severity of adverse effects can be increased when ondansetron is combined with Flibanserin.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with azelastine.


The risk or severity of adverse effects can be increased when methysergide is combined with risperidone.


The risk or severity of adverse effects can be increased when ketoconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with oxycodone.


The risk or severity of adverse effects can be increased when nimesulide is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when thiamylal is combined with METAXALONE.


The risk or severity of adverse effects can be increased when protriptyline is combined with meperidine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with amisulpride.


The risk or severity of adverse effects can be increased when protriptyline is combined with imipramine.


The risk or severity of adverse effects can be increased when isoniazid is combined with atorvastatin.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when clomipramine is combined with hydralazine.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when ethanol is combined with moclobemide.


The risk or severity of adverse effects can be increased when ethanol is combined with Escitalopram.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when etizolam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with acemetacin.


The risk or severity of adverse effects can be increased when amoxapine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when amiodarone is combined with metolazone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with halothane.


The risk or severity of adverse effects can be increased when labetalol is combined with phenmetrazine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with desipramine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with thiamylal.


The risk or severity of adverse effects can be increased when hydromorphone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Icatibant is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when miconazole is combined with barnidipine.


The risk or severity of adverse effects can be increased when Icatibant is combined with Halobetasol.


The risk or severity of adverse effects can be increased when amobarbital is combined with fludiazepam.


The risk or severity of adverse effects can be increased when tolterodine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when tolterodine is combined with pancuronium.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Eprosartan.


The risk or severity of adverse effects can be increased when fosinopril is combined with Nepafenac.


The risk or severity of adverse effects can be increased when betaxolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when ondansetron is combined with brotizolam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Salsalate is combined with alclometasone.


The risk or severity of adverse effects can be increased when carprofen is combined with estrone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with fenbufen.


The risk or severity of adverse effects can be increased when Etomidate is combined with Pizotifen.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when methscopolamine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when nicardipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with enoxacin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when methazolamide is combined with indapamide.


The risk or severity of adverse effects can be increased when triazolam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when chloroquine is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Icatibant is combined with triamcinolone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Remoxipride.


The risk or severity of adverse effects can be increased when mesoridazine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when metoprolol is combined with hydralazine.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with estrone.


The risk or severity of adverse effects can be increased when Lacidipine is combined with ropinirole.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when triflupromazine is combined with butamben.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Etomidate is combined with paroxetine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with ethotoin.


The risk or severity of adverse effects can be increased when carbamazepine is combined with prilocaine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when meclizine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when meclizine is combined with duloxetine.


The risk or severity of adverse effects can be increased when Valganciclovir is combined with didanosine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with clonidine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with amisulpride.


The risk or severity of adverse effects can be increased when sevoflurane is combined with propranolol.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Flupentixol.


The risk or severity of adverse effects can be increased when meperidine is combined with clidinium.


The risk or severity of adverse effects can be increased when meperidine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Butethal is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when cabergoline is combined with clomiphene.


The risk or severity of adverse effects can be increased when prednisone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with formoterol.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Spirapril is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when moclobemide is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when tropicamide is combined with propoxyphene.


The risk or severity of adverse effects can be increased when pentazocine is combined with clemastine.


The risk or severity of adverse effects can be increased when pentazocine is combined with lidocaine.


The risk or severity of adverse effects can be increased when tolmetin is combined with fluocinonide.


The risk or severity of adverse effects can be increased when leflunomide is combined with Salsalate.


The risk or severity of adverse effects can be increased when pentamidine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Alogliptin is combined with meperidine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with doxepin.


The risk or severity of adverse effects can be increased when alclofenac is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Tixocortol.


The risk or severity of adverse effects can be increased when Etomidate is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with diflunisal.


The risk or severity of adverse effects can be increased when metoprolol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when brotizolam is combined with sertraline.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with anastrozole.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Rufinamide is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when MELPERONE is combined with tizanidine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Etomidate.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with diflorasone.


The risk or severity of adverse effects can be increased when clorazepate is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when clorazepate is combined with bupivacaine.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when oxycodone is combined with zonisamide.


The risk or severity of adverse effects can be increased when diclofenac is combined with aspirin.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with propranolol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with clonidine.


The risk or severity of adverse effects can be increased when Difenoxin is combined with nefazodone.


The risk or severity of adverse effects can be increased when zaleplon is combined with bupivacaine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Etomidate.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with Pipamperone.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when oxycodone is combined with bromazepam.


The risk or severity of adverse effects can be increased when triamterene is combined with Aliskiren.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Masoprocol.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with malathion.


The risk or severity of adverse effects can be increased when temazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with thiamylal.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with sertraline.


The risk or severity of adverse effects can be increased when levorphanol is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when temazepam is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when ramipril is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when valsartan is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Tramadol.


The risk or severity of adverse effects can be increased when levorphanol is combined with triazolam.


The risk or severity of adverse effects can be increased when oxybutynin is combined with HEROIN.


The risk or severity of adverse effects can be increased when butabarbital is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when ipratropium is combined with biperiden.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when codeine is combined with clonazepam.


The risk or severity of adverse effects can be increased when codeine is combined with promethazine.


The risk or severity of adverse effects can be increased when doxepin is combined with clomipramine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when sulconazole is combined with gabapentin.


The risk or severity of adverse effects can be increased when doxepin is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Naloxegol.


The risk or severity of adverse effects can be increased when levorphanol is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when propofol is combined with Milnacipran.


The risk or severity of adverse effects can be increased when ketoprofen is combined with nimesulide.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with sulpiride.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nimodipine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when halothane is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when selegiline is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Eprosartan is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Trospium is combined with Propiverine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with propofol.


The risk or severity of adverse effects can be increased when midazolam is combined with lithium ion.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when isoflurane is combined with papaverine.


The risk or severity of adverse effects can be increased when apraclonidine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when rizatriptan is combined with droperidol.


The risk or severity of adverse effects can be increased when tretinoin is combined with nifedipine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with thiothixene.


The risk or severity of adverse effects can be increased when tizanidine is combined with promethazine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Etomidate is combined with tizanidine.


The risk or severity of adverse effects can be increased when metoprolol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with butamben.


The risk or severity of adverse effects can be increased when glutethimide is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with timolol.


The risk or severity of adverse effects can be increased when perphenazine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when lorazepam is combined with buspirone.


The risk or severity of adverse effects can be increased when Ximelagatran is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when loxapine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Salsalate is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Salsalate is combined with paramethasone.


The risk or severity of adverse effects can be increased when Eprosartan is combined with mesalamine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with fluocinonide.


The risk or severity of adverse effects can be increased when sulfathiazole is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Perospirone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Pizotifen is combined with Escitalopram.


The risk or severity of adverse effects can be increased when perphenazine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with flumethasone.


The risk or severity of adverse effects can be increased when Sacubitril is combined with mesalamine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with levorphanol.


The risk or severity of adverse effects can be increased when Azelnidipine is combined with pravastatin.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with formestane.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with tizanidine.


The risk or severity of adverse effects can be increased when venlafaxine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with doxepin.


The risk or severity of adverse effects can be increased when quazepam is combined with Aceprometazine.